BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: M F Silva J, Ladomenou F, Carpenter B, Chandra S, Sedlacek P, Formankova R, Grandage V, Friswell M, Cant AJ, Nademi Z, Slatter MA, Gennery AR, Hambleton S, Flood TJ, Lucchini G, Chiesa R, Rao K, Amrolia PJ, Brogan P, Wedderburn LR, Glanville JM, Hough R, Marsh R, Abinun M, Veys P. Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis. Blood Adv 2018;2:777-86. [PMID: 29618462 DOI: 10.1182/bloodadvances.2017014449] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Ambler WG, Nanda K, Onel KB, Shenoi S. Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives. Ann Med 2022;54:1839-50. [PMID: 35786149 DOI: 10.1080/07853890.2022.2095431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Alexander T, Greco R. Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2022. [PMID: 35578014 DOI: 10.1038/s41409-022-01702-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Achini‐gutzwiller FR, Snowden JA, Corbacioglu S, Greco R, Greco R, Alexander T, Snowden J, Badoglio M, Labopin M, Abinun M, Apte S, Arnold R, Domenech A, Brierley C, Burman J, Castilla‐llorente C, Cooper N, Daghia G, Daikeler T, Papa N, Vries‐bouwstra J, Farge D, Finke J, Hagglund H, Hawkey C, Henes J, Hiepe F, Jessop H, Kiely D, Kazmi M, Kirgizov K, Kramer E, Mancardi G, Marjanovic Z, Martin R, Martin T, Ma D, Moore J, Miller P, Muraro P, Oliveira M, Polushin A, Onida F, Simoes B, Puyade M, Resnick I, Ricart E, Rovira M, Saccardi R, Saif M, Sakellari I, Sharrack B, Snarski E, Scherer HU, Sossa C, Withers B, Wulffraat N, Zaccara E, Amrolia P, Ansari M, Balduzzi A, Corbacioglu S, Dalassier A, Dalle J, Diaz CH, Feuchtinger T, Locatelli F, Lucchini G, Galimard J, Vincent MG, Handgretinger R, Kleinschmidt K, Lawitschka A, Martinez AP, Peters C, Rocha V, Ruggeri A, Sedlacek P, Svec P, Toporski J, Yesilipek A; The EBMT Autoimmune Diseases (ADWP) and Paediatric Diseases (PDWP) Working Parties. Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation. Br J Haematol. [DOI: 10.1111/bjh.18176] [Reference Citation Analysis]
4 Kricke S, Rao K, Adams S. The significance of mixed chimaerism and cell lineage chimaerism monitoring in paediatric patients post haematopoietic stem cell transplant. Br J Haematol 2022. [PMID: 35421255 DOI: 10.1111/bjh.18190] [Reference Citation Analysis]
5 Quartier P. Systemic Juvenile Idiopathic Arthritis/Pediatric Still's Disease, a Syndrome but Several Clinical Forms: Recent Therapeutic Approaches. J Clin Med 2022;11:1357. [PMID: 35268449 DOI: 10.3390/jcm11051357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Muthu S, Jeyaraman M, Ranjan R, Jha SK. Remission is not maintained over 2 years with hematopoietic stem cell transplantation for rheumatoid arthritis: A systematic review with meta-analysis. WJBC 2021;12:0-0. [DOI: 10.4331/wjbc.v12.i6.0000] [Reference Citation Analysis]
7 Muthu S, Jeyaraman M, Ranjan R, Jha SK. Remission is not maintained over 2 years with hematopoietic stem cell transplantation for rheumatoid arthritis: A systematic review with meta-analysis. World J Biol Chem 2021;12:114-30. [PMID: 34904049 DOI: 10.4331/wjbc.v12.i6.114] [Reference Citation Analysis]
8 Ikeda Y, Nagase N, Tsuji A, Kitagishi Y, Matsuda S. Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease. World J Biol Chem 2021; 12(6): 104-113 [PMID: 34904048 DOI: 10.4331/wjbc.v12.i6.104] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Reiff DD, Stoll ML, Cron RQ. Precision medicine in juvenile idiopathic arthritis—has the time arrived? The Lancet Rheumatology 2021;3:e808-17. [DOI: 10.1016/s2665-9913(21)00252-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Erkens R, Esteban Y, Towe C, Schulert G, Vastert S. Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis: Refractory Arthritis, Recurrent Macrophage Activation Syndrome and Chronic Lung Disease. Rheum Dis Clin North Am 2021;47:585-606. [PMID: 34635293 DOI: 10.1016/j.rdc.2021.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Abinun M, Slatter MA. Haematopoietic stem cell transplantation in paediatric rheumatic disease. Curr Opin Rheumatol 2021;33:387-97. [PMID: 34261117 DOI: 10.1097/BOR.0000000000000823] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol 2021;2021:9323141. [PMID: 34123455 DOI: 10.1155/2021/9323141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Morelle G, Castelle M, Pinto G, Breton S, Bendavid M, Boussard C, Mouy R, Bader-Meunier B, Semeraro M, Faye A, Cavazzana M, Neven B, Blanche S, Quartier P, Moshous D. Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2021;19:27. [PMID: 33712044 DOI: 10.1186/s12969-021-00523-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Tang S, Li S, Zheng S, Ding Y, Zhu D, Sun C, Hu Y, Qiao J, Fang H. Understanding of cytokines and targeted therapy in macrophage activation syndrome. Semin Arthritis Rheum 2021;51:198-210. [PMID: 33385860 DOI: 10.1016/j.semarthrit.2020.12.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
15 Correale P, Saladino RE, Giannarelli D, Sergi A, Mazzei MA, Bianco G, Giannicola R, Iuliano E, Forte IM, Calandruccio ND, Falzea AC, Strangio A, Nardone V, Pastina P, Tini P, Luce A, Caraglia M, Caracciolo D, Mutti L, Tassone P, Pirtoli L, Giordano A, Tagliaferri P. HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis. Cells 2020;9:E1964. [PMID: 32854442 DOI: 10.3390/cells9091964] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
16 Walter JE, Ayala IA, Milojevic D. Autoimmunity as a continuum in primary immunodeficiency. Curr Opin Pediatr 2019;31:851-62. [PMID: 31693597 DOI: 10.1097/MOP.0000000000000833] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 12.5] [Reference Citation Analysis]
17 Vastert SJ, Jamilloux Y, Quartier P, Ohlman S, Osterling Koskinen L, Kullenberg T, Franck-Larsson K, Fautrel B, de Benedetti F. Anakinra in children and adults with Still's disease. Rheumatology (Oxford) 2019;58:vi9-vi22. [PMID: 31769856 DOI: 10.1093/rheumatology/kez350] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 25.0] [Reference Citation Analysis]
18 Lambert NC. Nonendocrine mechanisms of sex bias in rheumatic diseases. Nat Rev Rheumatol 2019;15:673-86. [PMID: 31597952 DOI: 10.1038/s41584-019-0307-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
19 Sullivan KM, Sarantopoulos S. Allogeneic HSCT for autoimmune disease: a shared decision. Nat Rev Rheumatol 2019;15:701-2. [DOI: 10.1038/s41584-019-0306-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Spierings J, van Laar JM. Is There a Place for Hematopoietic Stem Cell Transplantation in Rheumatology? Rheumatic Disease Clinics of North America 2019;45:399-416. [DOI: 10.1016/j.rdc.2019.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
21 Greco R, Labopin M, Badoglio M, Veys P, Furtado Silva JM, Abinun M, Gualandi F, Bornhauser M, Ciceri F, Saccardi R, Lankester A, Alexander T, Gennery AR, Bader P, Farge D, Snowden JA. Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties. Front Immunol 2019;10:1570. [PMID: 31333680 DOI: 10.3389/fimmu.2019.01570] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
22 Duarte RF, Labopin M, Bader P, Basak GW, Bonini C, Chabannon C, Corbacioglu S, Dreger P, Dufour C, Gennery AR, Kuball J, Lankester AC, Lanza F, Montoto S, Nagler A, Peffault de Latour R, Snowden JA, Styczynski J, Yakoub-Agha I, Kröger N, Mohty M; European Society for Blood and Marrow Transplantation (EBMT). Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant 2019;54:1525-52. [PMID: 30953028 DOI: 10.1038/s41409-019-0516-2] [Cited by in Crossref: 148] [Cited by in F6Publishing: 154] [Article Influence: 49.3] [Reference Citation Analysis]
23 Schneider R, Canny SP, Mellins ED. Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis. Cytokine Storm Syndrome 2019. [DOI: 10.1007/978-3-030-22094-5_21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Shamriz O, Chandrakasan S. Update on Advances in Hematopoietic Cell Transplantation for Primary Immunodeficiency Disorders. Immunol Allergy Clin North Am 2019;39:113-28. [PMID: 30466768 DOI: 10.1016/j.iac.2018.08.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
25 Immunosuppressants. Reactions Weekly 2018;1726:205-205. [DOI: 10.1007/s40278-018-53844-9] [Reference Citation Analysis]